Cargando…
Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477493/ https://www.ncbi.nlm.nih.gov/pubmed/32190971 http://dx.doi.org/10.1111/jdi.13254 |
| _version_ | 1783579912109555712 |
|---|---|
| author | Sheu, Wayne H‐H |
| author_facet | Sheu, Wayne H‐H |
| author_sort | Sheu, Wayne H‐H |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7477493 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74774932020-09-11 Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors Sheu, Wayne H‐H J Diabetes Investig Commentaries John Wiley and Sons Inc. 2020-04-16 2020-09 /pmc/articles/PMC7477493/ /pubmed/32190971 http://dx.doi.org/10.1111/jdi.13254 Text en © 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentaries Sheu, Wayne H‐H Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors |
| title | Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors |
| title_full | Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors |
| title_fullStr | Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors |
| title_full_unstemmed | Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors |
| title_short | Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors |
| title_sort | lowering the risk of gout: another benefits from the use of sodium–glucose cotransporter 2 inhibitors |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477493/ https://www.ncbi.nlm.nih.gov/pubmed/32190971 http://dx.doi.org/10.1111/jdi.13254 |
| work_keys_str_mv | AT sheuwaynehh loweringtheriskofgoutanotherbenefitsfromtheuseofsodiumglucosecotransporter2inhibitors |